BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12891533)

  • 1. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.
    Benamouzig R; Deyra J; Martin A; Girard B; Jullian E; Piednoir B; Couturier D; Coste T; Little J; Chaussade S
    Gastroenterology; 2003 Aug; 125(2):328-36. PubMed ID: 12891533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
    Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
    Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
    Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
    N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group.
    Bonithon-Kopp C; Kronborg O; Giacosa A; Räth U; Faivre J
    Lancet; 2000 Oct; 356(9238):1300-6. PubMed ID: 11073017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
    Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
    Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
    Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
    Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.
    Alberts DS; Martínez ME; Roe DJ; Guillén-Rodríguez JM; Marshall JR; van Leeuwen JB; Reid ME; Ritenbaugh C; Vargas PA; Bhattacharyya AB; Earnest DL; Sampliner RE
    N Engl J Med; 2000 Apr; 342(16):1156-62. PubMed ID: 10770980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Gastroenterology; 2016 Jan; 150(1):114-122.e4. PubMed ID: 26404953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
    Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
    Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
    Grau MV; Baron JA; Sandler RS; Wallace K; Haile RW; Church TR; Beck GJ; Summers RW; Barry EL; Cole BF; Snover DC; Rothstein R; Mandel JS
    J Natl Cancer Inst; 2007 Jan; 99(2):129-36. PubMed ID: 17227996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
    Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
    Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.